Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2026 16:01 ET | Source: Cerro de Pasco Resources

Cerro de Pasco Resources Awarded the Quiulacocha Tailings in AMSAC Public Bidding Process

Cerro de Pasco Resources wins AMSAC's bid to reprocess Quiulacocha tailings in Peru, subject to the execution of definitive agreements.
October 12, 2026 16:01 ET | Source: Ressources Cerro de Pasco Inc.

Ressources Cerro de Pasco remporte l’appel d’offres public d’AMSAC pour les résidus miniers de Quiulacocha

MONTRÉAL , 12 oct. 2026 (GLOBE NEWSWIRE) -- Ressources Cerro de Pasco Inc. (TSXV : CDPR | OTCQX : CDPMF | FRA : N8HP | BVL : CDPR) (« CDPR » ou la « Société ») annonce que le comité de vente...
October 12, 2026 16:01 ET | Source: NewHydrogen, Inc.

NewHydrogen to Release a Special Report on October 19, 2026

The Company will reveal a major engineering achievement SANTA CLARITA, CA, Oct. 12, 2026 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCQB: NEWH), the developer of ThermoLoop®, a breakthrough technology...
October 12, 2026 16:01 ET | Source: ArriVent BioPharma, Inc.

ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002

NEWTOWN SQUARE, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of...
October 12, 2026 16:01 ET | Source: Globus Medical

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

AUDUBON, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended...
October 12, 2026 16:01 ET | Source: Syndax Pharmaceuticals, Inc.

Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis

– Trial did not meet the primary endpoint of annualized rate of FVC decline – – Axatilimab was well tolerated with a safety profile comparable to placebo; no new safety signals were observed – –...
October 12, 2026 16:01 ET | Source: FormFactor, Inc.

FormFactor and Teradyne Announce Strategic Collaboration to Accelerate Next-Generation Semiconductor Testing

LIVERMORE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM), a leading provider of semiconductor test and measurement technologies, and Teradyne, Inc. (Nasdaq: TER), a...
October 12, 2026 16:00 ET | Source: Cytokinetics, Incorporated

Cytokinetics Announces Additional Data from ACACIA-HCM Presented at the HFSA Annual Scientific Meeting 2026

Additional Analyses from ACACIA-HCM Further Characterize Exercise Performance, Treatment Effect, Dose Titration and Safety of Aficamten in Non-Obstructive HCM SOUTH SAN FRANCISCO, Calif., Oct. 12,...
October 12, 2026 16:00 ET | Source: Bright MLS

Bright MLS September 2026 Housing Market Report: A Stalling Housing Market This Fall

North Bethesda, Md., Oct. 12, 2026 (GLOBE NEWSWIRE) -- As mortgage rates move to their highest levels in nearly three years, homebuyers are hitting affordability ceilings. In the Mid-Atlantic...
October 12, 2026 16:00 ET | Source: Glancy Prongay Wolke & Rotter LLP

Deadline Alert: Hyliion Holdings Corp. (HYLN) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 27, 2026 deadline to file a lead plaintiff motion in the class action...